Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Guan, Xin-Yuan  [Clear All Filters]
Journal Article
Chen S, Du Y, Guan X-Y, Yan Q. The current status of tumor microenvironment and cancer stem cells in sorafenib resistance of hepatocellular carcinoma. Front Oncol. 2023;13:1204513.
Luk ST, Ng K-Y, Zhou L, Tong M, Wong T-L, Yu H, Lo C-M, Man K, Guan X-Y, Lee TK, et al. Deficiency in embryonic stem cell marker REX1 activates MKK6-dependent p38 MAPK signaling to drive hepatocarcinogenesis. Hepatology. 2019.
Kong F-E, Tang Y-Q, Gong Y-F, Mo J-Q, Zhao Y, Li M-M, Cheng W, Li H-L, Zhu W-J, Liu S-S, et al. Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model. Hepatol Int. 2020.
Liu L, Dai Y, Chen J, Zeng T, Li Y, Chen L, Zhu Y-H, Li J, Li Y, Xie D, et al. Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition via Akt/GSK-3β/snail signaling. Hepatology. 2013.
Chai S, Ng K-Y, Tong M, Lau EY, Lee TK, Chan KWah, Yuan Y-F, Cheung T-T, Cheung S-T, Wang X-Q, et al. Oct4/miR-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells. Hepatology. 2016.
Chan LHei, Zhou L, Ng KYu, Wong TLok, Lee TK, Sharma R, Loong JH, Ching YPang, Yuan Y-F, Xie D, et al. PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation. Cell Rep. 2018;25(3):690-701.e8.
Man K-F, Zhou L, Yu H, Lam K-H, Cheng W, Yu J, Lee TK, Yun J-P, Guan X-Y, Liu M, et al. SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma. Nat Commun. 2023;14(1):7863.